Iranian Parliament’s Health Commission has announced that the government will continue to provide foreign currency at subsidized rates for medical drug imports and an earlier plan to stop subsidizing the imports has been scrapped.

ILNA reports that Mohammad Hossein Ghorbani, a member of the health commission, said the decision has been approved by the head of the Central Bank and the government’s team of economic experts.

He stressed that the subsidies are aimed at regulating the price of drugs. “The government planned to scrap the subsidies for medical drugs but pressure from MPs as well as public demand made them reverse their decision,” Ghorbani reported.

He added that the Health Ministry will be allotted a budget to import drugs at subsidized rates to keep them affordable.